MedTrace Logo

Cross-Over Evaluation of Two Lubricating Eye Drops

NCT00493662 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2008-01-15

No results posted yet for this study

Summary

To evaluate the efficacy of two lubricating eye drops for the treatment of dry eye signs and symptoms.

Conditions

  • Dry Eye

Interventions

DRUG

Polyethylene Glycol 400 0.4%

DRUG

Propylene Glycol 0.3%

DRUG

0.15% sodium Hyaluronate

DRUG

sodium chloride

DRUG

sodium phosphate monobasic

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Principal Investigators

  • Tom Kislan, OD · Hazleton Eye Specialists

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00493662 on ClinicalTrials.gov